230 related articles for article (PubMed ID: 30821336)
1. Elevated blood/lymphatic vessel ratio in pterygium and its relationship with vascular endothelial growth factor (VEGF) distribution.
Martín-López J; Pérez-Rico C; García-Honduvilla N; Buján J; Pascual G
Histol Histopathol; 2019 Aug; 34(8):917-929. PubMed ID: 30821336
[TBL] [Abstract][Full Text] [Related]
2. Increasing lymphatic microvessel density in primary pterygia.
Ling S; Liang L; Lin H; Li W; Xu J
Arch Ophthalmol; 2012 Jun; 130(6):735-42. PubMed ID: 22801834
[TBL] [Abstract][Full Text] [Related]
3. Expression of vascular endothelial growth factor C in human pterygium.
Fukuhara J; Kase S; Ohashi T; Ando R; Dong Z; Noda K; Ohguchi T; Kanda A; Ishida S
Histochem Cell Biol; 2013 Feb; 139(2):381-9. PubMed ID: 22910845
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of vascular endothelial growth factor implies the limbal origin of pterygia.
Gebhardt M; Mentlein R; Schaudig U; Pufe T; Recker K; Nölle B; Al-Samir K; Geerling G; Paulsen FP
Ophthalmology; 2005 Jun; 112(6):1023-30. PubMed ID: 15885787
[TBL] [Abstract][Full Text] [Related]
5. Regulation of vascular endothelial growth factor-C by tumor necrosis factor-α in the conjunctiva and pterygium.
Dong Y; Kase S; Dong Z; Fukuhara J; Tagawa Y; Ishizuka ET; Murata M; Shinmei Y; Ohguchi T; Kanda A; Noda K; Ishida S
Int J Mol Med; 2016 Aug; 38(2):545-50. PubMed ID: 27314284
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis in pterygium: morphometric and immunohistochemical study.
Marcovich AL; Morad Y; Sandbank J; Huszar M; Rosner M; Pollack A; Herbert M; Bar-Dayan Y
Curr Eye Res; 2002 Jul; 25(1):17-22. PubMed ID: 12518239
[TBL] [Abstract][Full Text] [Related]
7. Orbital Angiogenesis and Lymphangiogenesis in Thyroid Eye Disease: An Analysis of Vascular Growth Factors with Clinical Correlation.
Wong LL; Lee NG; Amarnani D; Choi CJ; Bielenberg DR; Freitag SK; D'Amore PA; Kim LA
Ophthalmology; 2016 Sep; 123(9):2028-36. PubMed ID: 27423310
[TBL] [Abstract][Full Text] [Related]
8. Angiogenic and lymphangiogenic microvessel density in breast carcinoma: correlation with clinicopathologic parameters and VEGF-family gene expression.
Choi WW; Lewis MM; Lawson D; Yin-Goen Q; Birdsong GG; Cotsonis GA; Cohen C; Young AN
Mod Pathol; 2005 Jan; 18(1):143-52. PubMed ID: 15297858
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis in pterygium: study of microvessel density, vascular endothelial growth factor, and thrombospondin-1.
Aspiotis M; Tsanou E; Gorezis S; Ioachim E; Skyrlas A; Stefaniotou M; Malamou-Mitsi V
Eye (Lond); 2007 Aug; 21(8):1095-101. PubMed ID: 16823458
[TBL] [Abstract][Full Text] [Related]
10.
Dong S; Wu X; Xu Y; Yang G; Yan M
Mol Vis; 2020; 26():510-516. PubMed ID: 32753832
[TBL] [Abstract][Full Text] [Related]
11. Expression of vascular endothelial growth factor and inducible nitric oxide synthase in pterygia.
Lee DH; Cho HJ; Kim JT; Choi JS; Joo CK
Cornea; 2001 Oct; 20(7):738-42. PubMed ID: 11588427
[TBL] [Abstract][Full Text] [Related]
12. Immunophenotypic characterization of telocyte-like cells in pterygium.
Maxia C; Murtas D; Isola M; Tamma R; Zucca I; Piras F; Ribatti D; Diana A; Perra MT
Mol Vis; 2018; 24():853-866. PubMed ID: 30713424
[TBL] [Abstract][Full Text] [Related]
13. Preliminary evidence of the presence of lymphatic vessels immunoreactive for D2-40 and Prox-1 in human pterygium.
Cimpean AM; Poenaru Sava M; Raica M; Ribatti D
Oncol Rep; 2011 Nov; 26(5):1111-3. PubMed ID: 21667034
[TBL] [Abstract][Full Text] [Related]
14. Nestin expression in pterygia: potential role in angiogenesis.
Tonthat CV; Di Girolamo N
Br J Ophthalmol; 2014 Jun; 98(6):801-7. PubMed ID: 24008823
[TBL] [Abstract][Full Text] [Related]
15. Decreased pigment epithelium-derived factor and increased vascular endothelial growth factor levels in pterygia.
Jin J; Guan M; Sima J; Gao G; Zhang M; Liu Z; Fant J; Ma JX
Cornea; 2003 Jul; 22(5):473-7. PubMed ID: 12827055
[TBL] [Abstract][Full Text] [Related]
16. The expression of vascular endothelial growth factor in mast cells promotes the neovascularisation of human pterygia.
Liang K; Jiang Z; Zhao B; Shen J; Huang D; Tao L
Br J Ophthalmol; 2012 Sep; 96(9):1246-51. PubMed ID: 22790437
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of lymphatic vessels in primary versus recurrent pterygium.
Ling S; Li Q; Lin H; Li W; Wang T; Ye H; Yang J; Jia X; Sun Y
Eye (Lond); 2012 Nov; 26(11):1451-8. PubMed ID: 22975656
[TBL] [Abstract][Full Text] [Related]
18. Pterygia: pathogenesis and the role of subconjunctival bevacizumab in treatment.
Mauro J; Foster CS
Semin Ophthalmol; 2009; 24(3):130-4. PubMed ID: 19437347
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis in the pathogenesis of pterygium.
Livezeanu C; Crăiţoiu MM; Mănescu R; Mocanu C; Crăiţoiu S
Rom J Morphol Embryol; 2011; 52(3):837-44. PubMed ID: 21892527
[TBL] [Abstract][Full Text] [Related]
20. Expression of vascular endothelial growth factor (VEGF) in macrophages, fibroblasts, and endothelial cells in pterygium treated with 5-Fluorouracil.
Hoyama E; Viveiros MM; Shiratori C; de Oliveira DE; Padovani CR; Selva D; Schellini SA
Semin Ophthalmol; 2015 May; 30(3):171-6. PubMed ID: 24171833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
